SCOPUS 정보 검색 플랫폼

Epilepsy Research

Volumn 48, Issue 3, 2002, Pages 217-219

Carbamazepine toxicity during combination therapy with levetiracetam: A pharmacodynamic interaction

(3) Sisodiya, Sanjay M a,b Sander, Josemir W A S a,b Patsalos, Philip N a,b

a UNIVERSITY COLLEGE LONDON (United Kingdom)

b EPILEPSY SOCIETY (United Kingdom)

Author keywords

Carbamazepine; Levetiracetam; New antiepileptic drug; Pharmacodynamic interactions

Indexed keywords

CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; CLOBAZAM; CLONAZEPAM; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PRIMIDONE; TOPIRAMATE; VALPROIC ACID;

ADULT; ARTICLE; ATAXIA; CASE REPORT; CONTROLLED DRUG RELEASE; DIPLOPIA; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; EPILEPSY; FEMALE; GAIT DISORDER; HUMAN; MALE; NAUSEA; NYSTAGMUS; PATIENT MONITORING; PRIORITY JOURNAL; VERTIGO; VOMITING;

ADULT; ANTICONVULSANTS; CARBAMAZEPINE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; PIRACETAM;

EID: 0036197123 PISSN: 09201211 EISSN: None Source Type: Journal
DOI: 10.1016/S0920-1211(01)00309-6 Document Type: Article

Times cited : (63)

References (11)

1
- 0033775210
- Efficacy and tolerability of levetiracetam 3000 mg/day in patients with refractory partial seizures: A multicentre, double-blind, responder-selected study evaluating monotherapy
- (2000) Epilepsia , vol.41 , pp. 1276-1283
- Ben-Menachem, E.¹ Falter, U.²

2
- 0034162331
- A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy
- (2000) Seizure , vol.9 , pp. 80-87
- Betts, T.¹ Waegemans, T.² Crawford, P.³

3
- 0033854805
- Levetiracetam for partial seizures. Results of a double-blind, randomized clinical trial
- (2000) Neurology , vol.55 , pp. 236-242
- Cereghino, J.J.¹ Biton, V.² Abou-Khalil, B.³ Dreifuss, F.⁴ Gauer, L.J.⁵ Leppik, I.⁶

4
- 0033765115
- Efficacy and tolerability of 1000-4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy
- (2000) Epilepsy Res. , vol.42 , pp. 89-95
- Grant, R.¹ Shorvon, S.D.²

5
- 0032563178
- Evidence of a unique profile of levetiracetam in rodent models of seizures and epilepsy
- (1998) Eur. J. Pharmacol. , vol.353 , pp. 191-206
- Klitgaard, H.¹ Matagne, A.² Gobert, J.³ Wulfert, E.⁴

6
- 0035954353
- Long-term continuation of levetiracetam in patients with refractory epilepsy
- (2001) Neurology , vol.56 , pp. 1772-1774
- Krakow, K.¹ Walker, M.² Sander, J.W.³

7
- 0032891765
- New antiepileptic drugs
- (1999) Ann. Clin. Biochem. , vol.36 , pp. 10-19
- Patsalos, P.N.¹

8
- 0033621925
- Pharmacokinetic profile of levetiracetam: Toward ideal characteristics
- (2000) Pharmacol. Ther. , vol.85 , pp. 77-85
- Patsalos, P.N.¹

9
- 0008647829
- Pathogenesis and pharmacology of epilepsy
- Crockard, A., Hayward, R., Hoff, J.T. (Eds.). Blackwell Science, Oxford, UK
- (2000) Neurosurgery: The Scientific Basis of Clinical Practice, third ed. , pp. 173-1194
- Patsalos, P.N.¹ Fish, D.R.² Shorvon, S.D.³

10
- 0033811027
- Multicentre double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory seizures
- (2000) Epilepsia , vol.41 , pp. 1179-1186
- Shorvon, S.D.¹ Lowernthal, A.² Janz, D.³ Bielen, E.⁴ Loiseau, P.⁵

11
- 0034883899
- 2+ currents
- (2001) Epilepsy Res. , vol.10 , pp. 279-286
- Zona, C.¹ Niespodziany, I.² Marchetti, C.³ Klitgaard, H.⁴ Bernardi, G.⁵ Margineanu, D.G.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.